MADRIGAL PHARMACEUTICALS, INC.

MDGL 10-K · FY 2025
API behind this page

MDGL FY 2025 request

Playground key active
Request URL /api/financials?ticker=MDGL&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 958,403 180,133 +432.1%
Operating Costs And Expenses 56,148 6,233 +800.8%
Research And Development Expense Excluding Acquired In Process Cost 388,525 236,718 +64.1%
Selling, General & Administrative 813,827 435,057 +87.1%
Show Business Segments breakouts
Reportable Segment 813,827 435,057 +87.1%
Operating Expenses 1,258,500 678,008 +85.6%
Operating Income -300,097 -497,875 +39.7%
Interest Income 37,364 46,654 -19.9%
Interest Expense -22,309 -14,671 -52.1%
Gains Losses On Extinguishment Of Debt -2,779 — —
Other Non-Operating Income (Expense) -463 — —
Net Income -288,284 -465,892 +38.1%
Show Business Segments breakouts
Reportable Segment -288,284 -465,892 +38.1%
Show Equity Components breakouts
Retained Earnings -288,284 -465,892 +38.1%
EPS (Basic) -12.85 -21.9 +41.3%
EPS (Diluted) -12.85 -21.9 +41.3%
Wtd Avg Shares (Basic) 22,434,310 21,272,962 +5.5%
Wtd Avg Shares (Diluted) 22,434,310 21,272,962 +5.5%
Revenue (FY) — — —
Show Business Segments breakouts
Reportable Segment 958,403 180,133 +432.1%
Cost of Revenue (FY) — — —
Show Business Segments breakouts
Reportable Segment -56,148 -6,233 -800.8%
Comprehensive Income -287,879 -465,892 +38.2%
Other Comprehensive Income 405 — —
Show Equity Components breakouts
Accumulated Other Comprehensive Income 405 — —

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 198,693 100,019 +98.7%
Restricted Cash Current 5,090 5,000 +1.8%
Available For Sale Securities Debt Securities Current 784,866 826,232 -5.0%
Accounts Receivable 134,476 53,822 +149.9%
Inventory 74,841 34,068 +119.7%
Prepaid Expenses & Other Current Assets 47,804 13,786 +246.8%
Total Current Assets 1,245,770 1,032,927 +20.6%
Non-Current Assets
Property, Plant & Equipment 1,499 2,190 -31.6%
Intangible Assets 7,381 4,729 +56.1%
Operating Lease Right-of-Use Assets 4,939 2,401 +105.7%
Total Assets 1,259,589 1,042,247 +20.9%
Current Liabilities
Accounts Payable 48,878 43,599 +12.1%
Accrued Liabilities 260,392 124,695 +108.8%
Operating Lease Liability Current 1,018 983 +3.6%
Total Current Liabilities 310,288 169,277 +83.3%
Non-Current Liabilities
Long-Term Debt 339,881 117,569 +189.1%
Operating Lease Liabilities 6,731 1,018 +561.2%
Liabilities Noncurrent 346,612 118,587 +192.3%
Total Liabilities 656,900 287,864 +128.2%
Long-Term Debt 339,881 — —
Stockholders' Equity
Common Stock 2 2 0.0%
Additional Paid In Capital Common Stock 2,692,280 2,556,095 +5.3%
Accumulated Other Comprehensive Income 873 468 +86.5%
Retained Earnings -2,090,466 -1,802,182 -16.0%
Total Stockholders' Equity 602,689 754,383 -20.1%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 873 468 +86.5%
Additional Paid In Capital 2,692,280 2,556,095 +5.3%
Common Stock 2 2 0.0%
Retained Earnings -2,090,466 -1,802,182 -16.0%
Total Liabilities & Equity 1,259,589 1,042,247 +20.9%
Preferred Stock Shares Outstanding 2,369,797 2,369,797 0.0%
Show Equity Components breakouts
Preferred Stock 2,369,797 2,369,797 0.0%
Preferred Stock Shares Issued 2,369,797 2,369,797 0.0%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Net Income -288,284 -465,892 +38.1%
Stock-Based Compensation 98,130 79,880 +22.8%
Depreciation & Amortization 1,506 1,096 +37.4%
Amortization Of Financing Costs And Discounts 1,604 2,089 -23.2%
Operating Lease Right Of Use Asset Periodic Reduction Increase 3,210 -400 +902.5%
Change in Accounts Receivable -80,654 -53,822 -49.9%
Change in Inventory -36,978 -34,068 -8.5%
Change in Prepaid & Other Assets -34,018 -10,636 -219.8%
Increase Decrease In Accounts Payable Trade 5,279 15,558 -66.1%
Increase Decrease In Accrued Liabilities 131,902 34,715 +280.0%
Increase Decrease In Accrued Interest Net Of Interest Received 5,971 -24,092 +124.8%
Net Cash from Operations -189,553 -455,572 +58.4%
Investing Activities
Purchases of Investments -1,047,510 -1,131,207 +7.4%
Proceeds From Sale And Maturity Of Available For Sale Securities 1,083,297 863,283 +25.5%
Payments To Acquire Intangible Assets -3,000 -5,000 +40.0%
Capital Expenditures -467 -1,462 +68.1%
Net Cash from Investing 32,320 -274,386 +111.8%
Financing Activities
Proceeds From Issuance Or Sale Of Equity (FY) — — —
Show Related Party Transactions By Related Party breakouts
Related Party 38,055 337,575 -88.7%
Proceeds From Issuance Of Secured Debt 350,000 — —
Debt Issuance Costs -10,407 — —
Repayments Of Secured Debt -121,664 — —
Net Cash from Financing 255,984 735,062 -65.2%
Supplemental
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 3,982 1,330 +199.4%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 13 — —
Net Change in Cash 98,764 5,104 +1835.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 203,783 105,019 +94.0%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key